Amgen Inc.
NASDAQAMGN exits its August 4 earnings print into a wave of upward analyst revisions, with the stock up nearly 3% on the day and a consensus that — for the first time in weeks — has started to catch up to where the shares are trading. The analyst response to Q2 was almost uniformly constructive. Six firms raised price targets on August 5 alone. Oppenheimer, Scotiabank, and BMO Capital…
A new long-form analysis for AMGN this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumAMGN exits its August 4 earnings print into a wave of upward analyst revisions, with the stock up nearly 3% on the day and a consensus that — for the first time in weeks — has started to catch up to where the shares…
Snapshot as of 6 Aug 2026
AMGN heads into Tuesday's Q2 report with short sellers still retreating, options traders marginally more defensive, and the stock itself now trading above the average analyst price target — a setup that puts the burden…
AMGN heads into its August 4 earnings report with a 7% week-on-week rally, a sharp drop in short interest, and options traders moving cautiously more defensive — a setup where the longs are winning but the hedgers are…
AMGN continues its quiet grind higher — up another 1.7% on the week to close at $368.10 — yet the analyst community used the move to trim targets rather than lift conviction, leaving the stock in an uncomfortable…
AMGN enters July having quietly put together its best monthly stretch in some time — up 7.5% over the past month and 4.4% on the week to close at $362.12 — yet the rally has done little to shift Wall Street's firmly…
Amgen heads into mid-June with both its short sellers and its options traders moving in the same direction — away from bearish conviction. The short rebuild that had been the dominant positioning story through late…
Amgen enters the first week of June with the defensive options tone that defined late May now visibly fading — while the short rebuild that had been running since mid-April appears to have lost momentum. The clearest…
Amgen heads into the summer with a quietly shifting setup — options traders are more cautious than they've been in months, short interest has been creeping higher for weeks, and the analyst community is clustered just…
Amgen enters its May 19 earnings call with options traders at their most defensive in months, a broad insider-selling cluster just behind it, and a stock that has lost 7% over the past month. The sharpest signal…
Amgen reports Q1 results on May 19 with options positioning flashing the most defensive signal in months — even as short sellers quietly reduce their bets. The standout heading into the print is in options. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AMGN — free to start on ORTEX.
Sign up for free →Open AMGN on ORTEX